Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG
Maraganore John converted 17,974 Hemab Therapeutics Holdings, Inc. shares (Form 4)
Traded May 4, 2026 · Filed May 4, 2026
On May 4, 2026, Maraganore John (Director) converted 17,974 Hemab Therapeutics Holdings, Inc. shares, leaving 35,948 shares. Filed May 4, 2026 (Form 4).
- Converted
- 17,974 shares
- Holding after
- 35,948 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Conversion | 17,974 | 35,948 | Direct |
Source
Related
- Hemab Therapeutics Holdings, Inc.
- Maraganore John
- Hemab Therapeutics Holdings, Inc. shareholders
- Schedule 13G · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Capital International Investors · Aug 12, 2026
- Schedule 13G · Invus Public Equities, L.P. · Aug 7, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026